Premium
Letter: psychological remission – a future endpoint in inflammatory bowel disease?
Author(s) -
Barreirode Acosta M.,
Gisbert J. P.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12766
Subject(s) - medicine , depression (economics) , inflammatory bowel disease , quality of life (healthcare) , disease , crohn's disease , infliximab , population , clinical endpoint , clinical trial , psychiatry , nursing , environmental health , economics , macroeconomics